News Insights
Regulatory updates, industry headlines and supply-chain alerts, reviewed before publishing.
Advertise Here
Reach qualified buyersBoost your visibility among pharma sourcing professionals and potential buyers.
- Grow your business with qualified leads
- GDS reports on your ad performance
- Targeted to this product's audience
- Direct enquiries from buyers
- Visibility to pharma professionals
Latest news
Showing 49–60 of 94 stories
FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
Today, the U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg…
S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility
Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer…
Merck and Moderna Prepare FDA Filing for Personalized mRNA Melanoma Vaccine Paired with Keytruda After Phase 3 Results
Merck and Moderna are preparing to seek FDA approval for a personalized mRNA melanoma vaccine used with Keytruda. No filing date has been set.
MEDDDICAL Announces AI-Driven RWE Analytics For MedTech & Pharma Organisations
MEDDDICAL has announced real-world data analysis and health market intelligence advisory services for MedTech and pharmaceutical companies…
Pharmaceutical Society of Uganda Withdraws Recognition of MUST Pharmacy Degree
The Pharmaceutical Society of Uganda (PSU) has withdrawn, with immediate effect, its recognition of the Bachelor of Pharmacy programme at Mbarara…
Samsung Bioepis secures 10-year biosimilar supply deal in Brazil
Samsung Bioepis said Tuesday it has secured a 10-year deal to exclusively supply its rare disease biosimilar SB12 to Brazil's public health system…
Zilbrysq Autoinjector Wins FDA Approval for Generalized Myasthenia Gravis, but Patients Must Wait Until Early 2027
FDA approved a once-daily Zilbrysq autoinjector for generalized myasthenia gravis. It launches in early 2027 with the same meningococcal infection…
Ryzumvi Eye Drop Wins FDA Approval for Presbyopia, with 27% Reaching the Main Goal in Its Larger Trial
The FDA approved Ryzumvi eye drops for presbyopia in adults. See how the nightly drop works, trial results, side effects, and what remains unknown.
Jemperli Wins Accelerated FDA Approval for a Rectal Cancer Subtype as Most Trial Patients Avoided Surgery
FDA gave Jemperli accelerated approval for dMMR rectal cancer. Most trial patients skipped surgery, but the data are interim. What patients should…
FDA approves Roche’s Enspryng as first at-home injection treatment for thyroid eye disease
The approval was supported by data from Roche’s pivotal Phase III SatraGO programme
Akeso Announces Opening of Global Phase II Study of Ivonescimab in First-Line Clear Cell Renal Cell Carcinoma…
HONG KONG, Oct. 19, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") and its partner Summit Therapeutics Inc. jointly announced…
Swiss Pharma Giant Roche Suspends German Capital Commitments Amid Dispute Over Drug Discounts
Roche halts German investments as chief Daniel Steiners warns Berlin that statutory drug rebates shatter trust in the market.
Page 5 of 8
Advertise on PharmaJungle - Free for 30 Days
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
- 30 days of free advertising
- Visibility across all pages
- Performance report with ad insights
- No setup or registration fee
Exclusive introductory offer for new advertisers
Top sources
Post your requirement
Get offers from suppliers
- Reach pharmaceutical suppliers
- Specify quality standard and quantity
- Set your shipping preference
- Receive offers directly
- Listed on our marketplace
Your product details and requirements may be published on the marketplace.
Create a New Buying Request
Fields marked with * are mandatory.